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Aim. Similar to PET, absolute quantitative imaging is becoming available in commercial SPECT/CT devices. This study’s goal
was to assess quantitative accuracy of activity recovery as a function of image reconstruction parameters and count statistics
in a variety of phantoms. Materials and Methods. We performed quantitative 99mTc-SPECT/CT acquisitions (Siemens Symbia
Intevo, Erlangen, Germany) of a uniform cylindrical, NEMA/IEC, and an anthropomorphic abdominal phantom. Background
activity concentrations tested ranged: 2–80 kBq/mL. SPECT acquisitions used 120 projections (20 s/projection). Reconstructions
were performed with the proprietary iterative conjugate gradient algorithm. NEMA phantom reconstructions were obtained as a
function of the iteration number (range: 4–48). Recovery coefficients, hot contrast, relative lung error (NEMAphantom), and image
noisewere assessed.Results. In all cases, absolute activity and activity concentrationweremeasuredwithin 10%of the expected value.
Recovery coefficients and hot contrast in hot inserts did not vary appreciably with count statistics. RC converged at 16 iterations
for insert size > 22mm. Relative lung errors were comparable to PET levels indicating the efficient integration of attenuation and
scatter corrections with adequate detector modeling. Conclusions. The tested device provided accurate activity recovery within 10%
of correct values; these performances are comparable to current generation PET/CT systems.
1. Introduction
Positron emission tomography (PET) is currently considered
the gold-standard modality for absolute quantification in
emission tomography. In contrast, up to now, single photon
emission computed tomography (SPECT) has been used
mostly for qualitative and semiquantitative clinical investiga-
tions; by consequence the signal at the pixel level (in units of
counts) is proportional to the number of measured events.
Compared to PET, SPECT suffers from inferior spatial
resolution and sensitivity but enables metabolic studies with
long half-life gamma emitter radioisotopes that are well-
suited tomatch the underlying tracermetabolism and biodis-
tribution of target processes over hours or days, in addition
to its capability of simultaneous multi-isotope imaging [1].
Similar to PET, absolute quantitative imaging has recently
become available in commercial SPECT/CTdevices [2]. A list
of potential uses of quantitative SPECT in a clinical setting
has been described extensively in the publication by Bailey
and Willowson [3].
One of the most important fields of application of quan-
titative SPECT imaging is internal dosimetry. In the recent
past, internal dosimetry has been successfully accomplished
with SPECT-only cameras [4]; however, the latest generation
of hybrid SPECT/CT scanners offer significant computa-
tional advantages thanks to the implementation of attenua-
tion, scatter, resolution recovery, and dead time corrections
[5, 6].The implementation of cross calibration procedures for
specific radioisotope/collimator combinations can achieve
absolute quantification in terms of Bq/cm3. Quantitative
SPECT calibration can be achieved by performing appropri-
ate phantom studies as reported by Zeintl et al. [7]. Such pro-
cedures should be repeated before each quantitative patient
scan and it is not supported by the commercial device.
Such quantitative performances, in assessing 99mTc activ-
ity concentration, in a ready-to-use environment are claimed
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by the newly developed Siemens Symbia Intevo SPEC/CT.
In particular the manufacturer claims a <10% accuracy
deviation in assessing 99mTc activity concentration using the
proprietary, low-energy, high-resolution collimator.
The goal of this study was to assess the quantitative accu-
racy of activity recovery as a function of image reconstruction
parameters and count statistics, first in a basic cylindrical
phantom and then in more anthropomorphic geometries
which mimic clinically relevant setups.
2. Material and Methods
Quantitative 99mTc-SPECT/CT acquisitions of a cylindrical
homogeneous phantom, a NEMA/IEC phantom, and an
anthropomorphic abdominal phantom were performed on a
Siemens Symbia Intevo SPECT/CT device (Siemens, Erlan-
gen, Germany) equipped with a low-energy, high-resolution
collimator. SPECT acquisitions were acquired with 120 pro-
jections (20 s/projection) and reconstructed using the pro-
prietary iterative conjugate gradient algorithm on a Siemens
Syngo work station. CT-based attenuation correction and
dual-energy window scatter correction were systematically
applied in SPECT reconstructions. The photopeak emission
energy window for 99mTc was set to 129–150 keV, while
the lower scatter window was set to 108–129 keV. SPECT
emission data were decay-corrected to the time of activity
administration; for each phantom study this corresponded to
the time of the calibration of the activity used for the phantom
preparation. Quantitative accuracy of the system was verified
with a monthly periodicity using a 57Co point source (whose
nominal activity was certified by the National Institute of
Standard and Technology or NIST, Gaithersburg, MD) for
the system energy and sensitivity calibration according to the
manufacturer’s specifications.
2.1. Different Phantom Studies Were Performed
2.1.1. Cylindrical Homogeneous Phantom. We started our
investigation by assessing quantitative accuracy in terms of
activity concentration recovery in a simple geometric con-
figuration consisting of a uniform background (cylindrical
homogenous phantom). The cylindrical phantom was 18 cm
long and 20 cm in diameter for an inner volume of 5683mL.
The SPECT reconstruction for the cylindrical phantom
employed 24 iterations, 4 subsets, and a Gaussian smoothing
with a full width at half maximum (FWHM) of 7.5mm.
This represents the standard quantitative reconstruction algo-
rithm in our clinical setup. The accuracy was evaluated by
a calibration factor (Bg. cal) which was the ratio between
the activity concentration measured in the reconstructed
SPECT phantombackground (𝑎𝑐,bg) and the expected activity
concentration (𝐴𝑐,bg) known from the phantom preparation:
Bg.cal =
𝑎𝑐,bg
𝐴𝑐,bg
. (1)
𝑎𝑐,bg was evaluated as the average on 5 circular region of
interests of 16 cm diameter centered on the cylinder axis
placed at different axial locations (Figure 1(a)). The image
Table 1: Background activity concentration (𝐴 𝑐,bg), total activity
deviation (Δ𝐴 tot), calibration factor (Bg. cal), and coefficient of vari-
ation (COV) for 4 SPECT acquisitions of a cylindrical homogeneous
phantom.
Homogeneous
scan number
𝐴 𝑐,bg
(kBq/mL)
Δ𝐴 tot
(%) Bg. cal COV%
Scan 1 22 3.9 1.05 13
Scan 2 20 4.1 1.04 12
Scan 3 18 3.5 1.04 12
Scan 4 2 8.6 1.09 38
noise was evaluated by the coefficient of variation (COV),
which is the ratio between the standard deviation and the
average signal measured from the phantom background:
COV (%) =
𝜎bg
𝑎𝑐,bg
× 100. (2)
To test the influence of the count statistics on quantitative
accuracy, we performed successive SPECT acquisitions at
different time points. The total activity in the phantom and
thus the background activity concentration decreased as a
function of time elapsed between the phantom prepara-
tion and the actual acquisition time. The nominal activity
concentration in the phantom background at the time of
the acquisition, the calibration factor, and the coefficient of
variation are reported in Table 1.
2.1.2. NEMA/IEC Phantom. A NEMA/IEC NU2 phantom
was also used to test the quantitative accuracy in a some-
how more anthropomorphic configuration; in particular this
phantom makes it possible to assess recovery coefficients as
well as hot contrast in spherical inserts as a function of the
insert size.
Six spherical inserts 10, 13, 17, 22, 28, and 37mm in
diameter were filled with an activity concentration (𝐴𝑐,sph)
8.5 times higher than the activity concentration present in the
phantom background (as reported in Table 2). A lung insert
was also available for this phantom and used to estimate a
relative lung error (Δ𝐶lung) (see Figure 1(b)).
For each spherical insert (𝑗) the recovery coefficients (RC)
were defined by
RC𝑗,max =
𝑎𝑐sph ,𝑗,max
𝐴𝑐,sph
,
RC𝑗,A50 =
𝑎𝑐sph ,𝑗,A50
𝐴𝑐,sph
,
(3)
where 𝑎𝑐,sph,𝑗,max is the measured maximum voxel value (in
terms of activity concentration) for a given spherical insert
(𝑗 = 1 to 6) and 𝑎𝑐,sph,𝑗,A50 is the average voxel value for
each hot insert volume of interest (VOI) defined by a 3D
isocontour at 50% adapted for background as defined in [8]
and recommended by the EANMGuidelines for FDG tumor
PET imaging [9].
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Figure 1: Cross section of the tree phantom employed for this study: (a) cylindrical phantom, (b) NEMA/IEC NU2 phantom, and (c) Kyoto
liver anthropomorphic phantom.
Table 2: SPECT acquisitions of the NEMA/IEC NU2 phantom: Activity concentration in the background (𝐴 𝑐,bg) and spherical inserts
(𝐴 𝑐,spheres), total activity deviation (Δ𝐴 tot), calibration factor (Bg. cal) and coefficient of variation (COV), lung variability (Δ𝐶 lung), and
hot contrast (𝑄𝐻) for the 22mm diameter hot insert.
NEMA
scan
number
𝐴 𝑐,bg 𝐴 𝑐,spheres Δ𝐴 tot (%) Bg. cal COV% Δ𝐶 lung%
𝑄𝐻 (%)
(22mm)
Scan 1 23.27 196.87 2.5 1.06 20 5.78 65
Scan 2 18.30 154.82 1.1 1.03 24 5.70 67
Scan 3 12.32 104.20 −1 0.98 28 7.79 65
Scan 4 1.46 12.36 4 1.01 55 20.47 65
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Table 3: SPECT acquisitions of the liver phantom: activity concentration in the background (𝐴 𝑐,bg) and spherical inserts (𝐴 𝑐,spheres), total
activity deviation (Δ𝐴 tot), calibration factor (Bg. cal) and coefficient of variation (COV), and hot contrast (𝑄𝐻) for the three inserts.
Liver
scan
number
𝐴 𝑐,bg
kBq/mL
𝐴 𝑐,Sph.
kBq/mL Δ𝐴 tot (%) Bg. cal COV% 𝑄𝐻 40mm 𝑄𝐻 30mm 𝑄𝐻 20mm
Scan 1 77.79 404.57 1.9 1.08 8.47 68 51 30
Scan 2 62.13 323.09 0.1 1.07 8.99 67 51 29
Scan 3 42.05 218.70 −0.1 1.06 12.12 67 54 33
Scan 4 4.99 25.95 5.8 1.07 43.25 71 51 33
According to standard National Electrical Manufacturers
Association (NEMA) NU2 standard, the hot contrast (𝑄𝐻)
was defined by
𝑄𝐻,𝑗 (%) =
(𝑎𝑐,sph,𝑗/𝑎𝑐,bg) − 1
(𝐴𝑐,sph/𝐴𝑐,bg) − 1
× 100, (4)
while inserting the relative error in the lung insertwas defined
by:
Δ𝐶lung (%) =
𝑎𝑐,lung
𝐴𝑐,bg
× 100, (5)
where 𝑎𝑐,lung is the average activity concentrationmeasured in
a cylindrical volume of interest 3 cm in diameter and 16 cm in
length placed into the lung insert.
SPECT reconstructions of NEMA/IEC NU2 phantom
acquisition Scan 1 were performed by varying the iteration
number (iteration range: 4–48, 4 subsets, Gaussian smooth-
ing of FWHM 7.5mm) to study the impact of this parameter
on recovery coefficients (RC), hot contrast relative lung error,
and image noise (COV).
Background activity concentration (ACbg) as well as ac-
tivity concentration in spherical inserts were decreasing as
a function of time between successive SPECT acquisitions
of the NEMA phantom as summarized in Table 2, where 16
iterations were used for the reconstruction.
2.1.3. Kyoto Liver Anthropomorphic Phantom. Lastly, we as-
sessed quantitative accuracy using an anthropomorphic
abdominal phantom (commercial Kyoto Liver/Kidney phan-
tom, Nuclemed, Roeselare, Belgium) that includes a liver
insert (volume = 1.8 L) with 3 hot-spheres (20–30–40mm
diameter, 5.2 : 1 hot-sphere to liver activity concentration
ratio) and a high-density element such as a lumbar spine
insert (Figure 1(c)). We assessed the hot contrast for the three
spherical inserts.
Liver phantom reconstructions were performed using 16
iterations and 4 subsets (FWHM= 7.5mm); the only variable
was the time elapsed between the phantom preparation and
the SPECT acquisition to evaluate quantitative accuracy as a
function of counting statistics.
For the three phantom configurations tested, the total
activity in the reconstructed field of view (that contains the
whole phantom, total background plus overall insert activity)
was also evaluated and compared to the nominal total activity
known from the phantom preparation as reported in Table 3.
Image coregistrations of SPECT and CT data as well
as volume of interest segmentation (based on CT data)
were performed using PMOD (release 3.4) software (PMOD
Technologies Ltd., Zurich, Switzerland).
In all phantom acquisitions the total recovered activity
(𝐴 tot,rec) in the field of viewwas compared to the total activity
(𝐴 tot) known at the phantom preparation to derive the total
activity deviation:
Δ𝐴 tot (%) =
𝐴 tot,rec − 𝐴 tot
𝐴 tot
× 100. (6)
3. Results and Discussion
As reported in Tables 1, 2, and 3, the background activity
concentration for the different phantom configurations we
tested exhibited overall good quantitative accuracy.Themea-
sured values were within 10% of the expected values, even at
low activity concentrations (<10 kBq/mL), thus in agreement
with the accuracy level (<10%) stated by themanufacturer. As
expected, the COV increased with decreasing statistics.
For the NEMA phantom (NEMA Scan 1), RC values
were comparable to PET derived reference levels reported
in the EANM guidelines for FDG PET for tumor imaging:
version 1.0 [9]. Nevertheless, because of the inferior intrinsic
spatial resolution of SPECT compared to PET, RC values in
small volumes remain lower than present generation time-
of-flight (TOF) PET adopting resolution recovery methods
such as the point spread function correction. As shown in
Figure 2, RC values increased less than linearly as a function
of the iteration number.The RC values for a 22mm hot insert
showed a relative increment (mean/max) of 13/18%, 8.5/12%,
and 4/7.5% when varying from It = 4 to 8, 12 to 24, and 24 to
48, respectively.
The convergence for activity concentration recovery in
insert with diameter > 24mm was satisfactory (less than 5%
variation) for It ≥ 16, while more iterations are suitable for
activity recoveries in smaller volumes.
The lung relative error (Table 2) was less than 10% for
tested background activity concentrations> 12 kBq/mL. Such
lung error values are comparable to what can be obtained
in 18F-FDG TOF PET phantom scans [10]. The lung relative
error increased with lower statistic and was found to be
approximately 20% for 𝐴𝑐,bg of 1.5 kBq/mL (NEMA Scan 4).
Recovery coefficients and hot contrast (𝑄𝐻) measured
in NEMA (Table 2) and liver phantom (Table 3) scans with
a fixed reconstruction setting (It = 16, Ss = 4, and FWHM
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Figure 2: Recovery coefficient (RCmax and RCA50) as a function of the insert diameter with a different number of iterations (It range: 4–48)
for the iterative reconstruction algorithm using the NEMA/IEC phantom.
(a) (b)
Figure 3: (a) 99mTc-MAASPECT/CTprior to Y-90 radioembolisation after administration of 105.8MBq of 99mTc-MAA to the right lobe of the
liver (volume = 1290mL, segmentation in violet). In this specific case the recovered total activity on the SPECT field of view was 98.2MBq
that is 7% less than the total administered activity. Average activity concentration in the normal parenchyma was 35.6 kBq/ml (range: 0–
151 kBq/ml, volume = 987mL). In the region of high uptake (typical of tumor hypervascularisation, volume = 303mL, segmented in green)
the averaged activity concentration was 107 kBq/ml (range: 49–421 kBq/mL). (b) Bone SPECT/CT of a patient administered with 937MBq of
99mTc-labeled diphosphonates. A hot lesion due to a degenerative arthrosis is visible on the left lumbar posterior vertebral articulation (L5-S1)
with average activity concentration of 224.5 kBq/mL (range: 172–328 kBq/mL) with an average bone uptake into the SPECT field of view of
60 kBq/mL (SUVmax = 46 g/mL).
= 7.5mm) did not vary appreciably with count statistics.
The total activity contained in the SPECT field of view
was measured for each phantom scan and the quantitative
agreement with the actual activity contained in the phantom
was within 9% (range [+3.5% to 8.6%]) for the cylindrical
uniform phantom, 5% (range [−0.1% to +4%]) for the NEMA
phantom, and 6% (range [−1% to +5.8%]) for the liver
phantom of the true total activity.
In vivo validation of 99mTc SPECT/CT quantification was
performed on quantitative SPECT/CT of 99mTc-macroag-
gregated albumin (MAA) liver distribution for dosimetry
assessments prior to Y-90 radioembolisation in a series of 10
patients. The recovered total activity in the SPECT field of
view (abdominal region centered on the liver) was on average
8% less of the total administered activity. This underestima-
tion can be explained by the fact that part of the administered
albumins were not in the field of view of the SPECT/CT
acquisition as results of extrahepatic shunts in the pelvic
region and the upper part of the lungs. An example is given
in Figure 3(a). An example of quantification in a bone 99mTc-
labeled diphosphonate SPECT/CT is given in Figure 3(b).
Quantitative methods in 99mTc SPECT can achieve a 5%
level of accuracy as reported by Bailey and Willowson, ([3]
and references therein). This level of accuracy is compatible
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with results obtained in most of the phantom configuration
tested by us. The tested SPECT/CT device provided a simple
and ready-to-use way to achieve absolute quantification of
99mTc at the price of a periodic calibration, once per month as
recommended by the vendor, consisting in the measurement
of the detector sensitivity with a NIST certified Co-57 source
in extrinsic modality (with the low-energy high-resolution
collimator on place). The time required by this calibration
procedure depends on the source activity; a static acquisition
with a total statistic of 5000 k counts is required. Including
collimator mounting, energy peaking verification, and point
source calibration, no more than an hour is required in our
experience when the source activity enables a >5 k counts/s
count rate as requested by vendor specifications.
4. Conclusion
Absolute quantification in commercial SPECT/CT is now
commercially available and a clinical reality. In this work,
we tested quantitative accuracy of 99mTc SPECT in differ-
ent phantom configurations, which progressively mimics
anthropomorphic geometry. The tested SPECT/CT scanner
provided satisfactory accuracy for both background activity
concentration and total activity recovery. Relative lung error
evaluated in a NEMA/IEC NU2 phantom study setup was
comparable to levels achievable in modern PET scanners
using 18F-FDG. This last result demonstrates the efficient
integration of attenuation and scatter corrections with ade-
quate detector/collimator modeling. Activity recovery in a
hot insert is affected by the partial volume effect and needs to
be assessed for each clinical setup. Reconstruction parameters
influence RC (and thus SUV), and optimization is recom-
mended according to clinical requirements. At fixed recon-
struction parameters, RC and hot contrast have shown little
variation within the tested counting statistics range. Reliable
and ready-to-use SPECT quantification is now available
commercially and has the potential to improve monitoring
clinical processes and their evolution with therapy, as well as
assessing internal radiation dosimetry.
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